NetTargets
PrivateLast Round
VC Round
May 1, 2024
Total Funding Raised
$7.17M
Company Overview
NetTargets operates in Healthcare & Life Sciences and is based in Daejeon. Its latest recorded funding round was a VC Round in May 2024.
NetTargets is a biotechnology company that provides a drug discovery platform based on AI-enhanced systems biology to identify novel drug targets and simulate treatment strategies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NetTargets Comparables
Compare NetTargets with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Callio Therapeutics | 83% | |
| Phrontline Biopharma | 83% | |
| Eli Lilly and Company | 75% |
For institutional investors. Book with your work email.
NetTargets Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 1, 2024 | ||||
| Series A | Jun 28, 2021 | ||||
| Pre Seed | Apr 16, 2020 | ||||
| Seed | Oct 25, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NetTargets Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DA Value Investment | Series A |
| CKD Venture Capital | Series A |
| Bluepoint Partners | Seed |
| Friend Investment Partners | Pre Seed, Series A |
| GU Equity Partners | Series A |
| We Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2025
Developing dual-payload ADCs with Debiopharm to treat resistant cancers.
- Oct 30, 2025
Collaborating with Debiopharm on dual-payload Antibody-Drug Conjugates (ADCs).
For institutional investors. Book with your work email.
NetTargets Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NetTargets's valuation, stock price, and market status.
Is NetTargets a public or private company?
NetTargets is a private company.
What is the current stock price of NetTargets?
NetTargets is a private company, so its shares have no public market price. Caplight tracks NetTargets's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NetTargets worth (valuation)?
Valuation information for NetTargets is not publicly available.
Can I buy NetTargets stock?
NetTargets shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NetTargets's last funding round?
NetTargets's most recent funding round was VC Round on May 1, 2024.
Who are the main investors in NetTargets?
Key investors in NetTargets include Bluepoint Partners.
Will NetTargets IPO soon?
No public IPO plans have been announced for NetTargets.
How can I track NetTargets secondary market activity?
Caplight tracks bids, offers, and trades in NetTargets's shares on secondary markets.